Search Results

There are 14077 results for: content related to: Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis

  1. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  2. Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice

    The Journal of Clinical Pharmacology

    Volume 55, Issue S3, March 2015, Pages: S39–S50, Niels Vande Casteele and Ann Gils

    Version of Record online : 23 FEB 2015, DOI: 10.1002/jcph.374

  3. Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 7, July 2012, Pages: 1199–1206, Benjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, Marine Desroches, Gauthier Louis, Chiara De Cassan, Clotilde Baudry, Jean-Marc Gornet, Pierre Desreumaux, Dominique Emilie, Jean-Frédéric Colombel and Matthieu Allez

    Version of Record online : 29 AUG 2011, DOI: 10.1002/ibd.21839

  4. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  5. You have free access to this content
    Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 10, November 2015, Pages: 1158–1169, K. Papamichael, T. Van Stappen, V. Jairath, K. Gecse, R. Khanna, G. D'Haens, S. Vermeire, A. Gils, B. G. Feagan, B. G. Levesque and N. Vande Casteele

    Version of Record online : 13 SEP 2015, DOI: 10.1111/apt.13402

  6. You have free access to this content
    Light on the Horizont: biologicals in Behçet uveitis

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: 297–306, Dicle Hazirolan, Nicole Stübiger and Uwe Pleyer

    Version of Record online : 20 APR 2012, DOI: 10.1111/j.1755-3768.2011.02348.x

  7. The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 10, November 2015, Pages: 1192–1199, G. Dumitrescu, A. Amiot, P. Seksik, C. Baudry, C. Stefanescu, C. Gagniere, M. Allez, J. Cosnes and Y. Bouhnik

    Version of Record online : 10 SEP 2015, DOI: 10.1111/apt.13393

  8. Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety

    The Journal of Clinical Pharmacology

    Volume 55, Issue S3, March 2015, Pages: S60–S74, Zhenhua Xu, Hugh M. Davis and Honghui Zhou

    Version of Record online : 23 FEB 2015, DOI: 10.1002/jcph.380

  9. Genes associated with intestinal permeability in ulcerative colitis: Changes in expression following infliximab therapy

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1399–1410, Gary Toedter, Katherine Li, Sarah Sague, Keying Ma, Colleen Marano, Michael Macoritto, Jennifer Park, Renée Deehan, Andrea Matthews, Gary D. Wu, James D. Lewis, Ingrid Arijs, Paul Rutgeerts and Frédéric Baribaud

    Version of Record online : 4 JAN 2012, DOI: 10.1002/ibd.22853

  10. You have free access to this content
    Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro

    Inflammatory Bowel Diseases

    Volume 18, Issue 3, March 2012, Pages: 401–408, Anne Christine W. Vos, Manon E. Wildenberg, Ingrid Arijs, Marjolijn Duijvestein, Auke P. Verhaar, Gert de Hertogh, Séverine Vermeire, Paul Rutgeerts, Gijs R. van den Brink and Daniel W. Hommes

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21818

  11. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery

    Inflammatory Bowel Diseases

    Volume 18, Issue 7, July 2012, Pages: 1207–1213, Michael S. Kasparek, Andreas Bruckmeier, Florian Beigel, Mario H. Müller, Stephan Brand, Ulrich Mansmann, Karl-Walter Jauch, Thomas Ochsenkühn and Martin E. Kreis

    Version of Record online : 16 SEP 2011, DOI: 10.1002/ibd.21860

  12. Mucosal healing in Crohn's disease: A systematic review

    Inflammatory Bowel Diseases

    Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen and Greg Moore

    Version of Record online : 26 APR 2012, DOI: 10.1002/ibd.22977

  13. Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 11, June 2015, Pages: 1094–1103, M. J. Rosen, P. Minar and A. A. Vinks

    Version of Record online : 23 MAR 2015, DOI: 10.1111/apt.13175

  14. You have free access to this content
    Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 613–623, J. P. Gisbert, A. C. Marín, A. G. McNicholl and M. Chaparro

    Version of Record online : 4 FEB 2015, DOI: 10.1111/apt.13083

  15. Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 391–405, J. P. Gisbert, A. C. Marín and M. Chaparro

    Version of Record online : 15 JUN 2015, DOI: 10.1111/apt.13276

  16. Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation

    Pediatric Transplantation

    Volume 16, Issue 7, November 2012, Pages: 771–778, Jun Yang, Daniel Ka Leung Cheuk, Shau Yin Ha, Alan Kwok Shing Chiang, Tsz Leung Lee, Marco Hok Kung Ho and Godfrey Chi Fung Chan

    Version of Record online : 20 AUG 2012, DOI: 10.1111/j.1399-3046.2012.01756.x

  17. Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1480–1487, Toshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, Satoshi Motoya, Hiroaki Ito, Kenta Motegi, Yoshitaka Kinouchi, Masakazu Takazoe, Yasuo Suzuki, Takayuki Matsumoto, Kazuhiko Kawakami, Takayuki Matsumoto, Ichiro Hirata, Shinji Tanaka, Toshifumi Ashida and Toshiyuki Matsui

    Version of Record online : 10 OCT 2011, DOI: 10.1002/ibd.21886

  18. You have free access to this content
    Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1324–1332, F. Baert, N. Vande Casteele, S. Tops, M. Noman, G. Van Assche, P. Rutgeerts, A. Gils, S. Vermeire and M. Ferrante

    Version of Record online : 2 OCT 2014, DOI: 10.1111/apt.12968

  19. Biologic Response Modifiers and Pediatric Psoriasis

    Pediatric Dermatology

    Volume 32, Issue 3, May/June 2015, Pages: 303–320, Fernanda Bellodi Schmidt and Kara N. Shah

    Version of Record online : 26 FEB 2015, DOI: 10.1111/pde.12547

  20. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1608–1616, Glen A. Doherty, Rebecca A. Miksad, Adam S. Cheifetz and Alan C. Moss

    Version of Record online : 8 SEP 2011, DOI: 10.1002/ibd.21904